evertex fabrinology limited (TPE:1470)
Taiwan · Delayed Price · Currency is TWD 24.50
+0.50 (2.08%)
Aug 26, 2026, 1:30 PM CST
TPE:1470 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,058 | 1,955 | 1,904 | 1,655 | 1,561 | 1,522 | |
Market Cap Growth | 18.23% | 2.70% | 15.03% | 6.04% | 2.54% | -1.93% |
Enterprise Value | 1,665 | 1,656 | 1,555 | 1,260 | 1,201 | 1,262 |
Last Close Price | 24.00 | 22.10 | 20.51 | 17.33 | 15.98 | 14.94 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.62 | 29.07 | 19.57 | 33.55 | 47.53 | 23.35 |
PS Ratio | 2.70 | 2.43 | 2.42 | 2.53 | 1.85 | 1.70 |
PB Ratio | 2.04 | 1.93 | 1.84 | 1.68 | 1.60 | 1.51 |
P/TBV Ratio | 2.04 | 1.93 | 1.84 | 1.68 | 1.61 | 1.51 |
P/FCF Ratio | 23.18 | 31.51 | 22.40 | 14.96 | 9.62 | - |
P/OCF Ratio | 15.17 | 19.32 | 17.10 | 11.44 | 8.25 | 34.73 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.18 | 2.06 | 1.97 | 1.92 | 1.42 | 1.41 |
EV/EBITDA Ratio | 12.53 | 13.12 | 11.64 | 15.76 | 10.26 | 9.68 |
EV/EBIT Ratio | 18.37 | 19.83 | 17.80 | 37.77 | 17.56 | 16.08 |
EV/FCF Ratio | 18.75 | 26.68 | 18.30 | 11.39 | 7.40 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 | 0.04 |
Debt / EBITDA Ratio | 0.21 | 0.23 | 0.27 | 0.54 | 0.32 | 0.29 |
Debt / FCF Ratio | 0.32 | 0.48 | 0.43 | 0.41 | 0.24 | - |
Net Debt / Equity Ratio | -0.39 | -0.34 | -0.36 | -0.41 | -0.38 | -0.31 |
Net Debt / EBITDA Ratio | -3.05 | -2.76 | -2.76 | -5.00 | -3.15 | -2.41 |
Net Debt / FCF Ratio | -4.43 | -5.61 | -4.35 | -3.61 | -2.27 | 238.93 |
Asset Turnover | 0.63 | 0.68 | 0.67 | 0.57 | 0.70 | 0.74 |
Inventory Turnover | 3.64 | 3.72 | 3.66 | 2.92 | 2.60 | 2.93 |
Quick Ratio | 2.68 | 3.25 | 2.84 | 3.36 | 2.86 | 2.00 |
Current Ratio | 3.48 | 4.42 | 3.96 | 4.40 | 4.23 | 3.27 |
Return on Equity (ROE) | 11.36% | 6.57% | 9.63% | 5.04% | 3.32% | 6.61% |
Return on Assets (ROA) | 4.71% | 4.40% | 4.63% | 1.82% | 3.56% | 4.04% |
Return on Invested Capital (ROIC) | 12.11% | 10.21% | 11.26% | 4.84% | 6.93% | 9.85% |
Return on Capital Employed (ROCE) | 8.90% | 8.20% | 8.40% | 3.30% | 7.00% | 7.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.41% | 3.44% | 5.11% | 2.98% | 2.10% | 4.28% |
FCF Yield | 4.31% | 3.17% | 4.46% | 6.68% | 10.39% | -0.09% |
Dividend Yield | 2.75% | 2.94% | 4.92% | 3.35% | 2.82% | 5.35% |
Payout Ratio | 77.74% | 128.78% | 51.12% | 78.21% | 208.92% | 55.25% |
Buyback Yield / Dilution | -0.47% | 0.05% | -0.09% | -0.00% | 0.05% | -0.06% |
Total Shareholder Return | 2.29% | 2.99% | 4.84% | 3.35% | 2.87% | 5.30% |